coproporphyrin i

Coproporphyrin I dihydrochloride is an appropriate clinical biomarker to recapitulate drug-drug interactions mediated by OATP inhibition.

Coproporphyrin I, an endogenous metabolite found in urine and blood, is utilized in researching liver disease and porphyria [1] [2] [3] [4].

Coproporphyrin I tetramethyl ester is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Coproporphyrin III is a derivative of porphyrin.

Coproporphyrin III dihydrochloride, a bioactive compound secreted by nostril- and skin-associated Propionibacterium species, promotes the aggregation of Staphylococcus aureus during early stationary phase growth at a low pH of 4-6. In addition, it facilitates plasma-independent biofilm formation by S. aureus on non-living surfaces. This compound could play a crucial role in mediating the accumulation and biofilm development of S. aureus in nasal passages or other locations where both Propionibacterium and S. aureus coexist.